Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications.

Salukhe TV, Dimopoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP.

Circulation. 2004 Apr 20;109(15):1848-53. Epub 2004 Apr 5.

2.

Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.

Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB, Li Y, O'Connor CM, Shaw LK, Califf RM.

Ann Intern Med. 2005 Apr 19;142(8):593-600.

PMID:
15838065
3.

The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.

J Am Coll Cardiol. 2006 Jun 6;47(11):2310-8. Epub 2006 May 4.

4.

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.

Eur Heart J. 2007 Jan;28(1):42-51. Epub 2006 Nov 16.

PMID:
17110403
5.

Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.

Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4 Suppl):67-83.

PMID:
16274418
6.

ICD: a qualitative study of patient experience the first year after implantation.

Kamphuis HC, Verhoeven NW, Leeuw R, Derksen R, Hauer RN, Winnubst JA.

J Clin Nurs. 2004 Nov;13(8):1008-16.

PMID:
15533107
7.

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group.

Circulation. 2004 Dec 21;110(25):3760-5. Epub 2004 Dec 6.

8.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

9.

Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II.

Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW; Multicenter Automatic Defibrillator Implantation Trial II.

Med Care. 2007 May;45(5):377-85.

PMID:
17446823
10.

Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K.

Circulation. 2007 May 15;115(19):2474-80. Epub 2007 Apr 30.

11.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

12.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

13.

Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr.

Circulation. 2004 Oct 5;110(14):1885-9. Epub 2004 Sep 27.

14.

Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.

Jönsson B, Carides GW, Burke TA, Dasbach EJ, Lindholm LH, Dahlöf B; LIFE Study Group.

J Hypertens. 2005 Jul;23(7):1425-31.

PMID:
15942467
15.

Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.

Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B.

J Cardiovasc Electrophysiol. 2005 May;16(5):478-82.

PMID:
15877617
16.

Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.

Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung E, Menon S, Nallamothu BK, Chan PS.

J Am Coll Cardiol. 2007 Jan 2;49(1):50-8. Epub 2006 Dec 13.

17.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators.

Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.

18.

Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?

Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ.

Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):522-8. Review.

PMID:
16186850
19.

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.

J Card Fail. 2008 Feb;14(1):9-18. doi: 10.1016/j.cardfail.2007.08.003.

PMID:
18226768
20.

Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU; MADIT-II Investigators.

J Am Coll Cardiol. 2006 May 2;47(9):1811-7. Epub 2006 Apr 17.

Supplemental Content

Support Center